Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

2.39
-0.0100-0.42%
Pre-market: 2.450.0600+2.51%08:59 EDT
Volume:965.13K
Turnover:2.33M
Market Cap:376.53M
PE:4.92
High:2.47
Open:2.40
Low:2.38
Close:2.40
Loading ...
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 28, 2020

Correspondence

CORRESP [Cover] - Correspondence
Apr 28, 2020

Major Issues Report

Current report, item 5.02
Mar 30, 2020

Major Issues Report

Current report, item 8.01
Mar 24, 2020

Major Issues Report

Current report, item 1.01
Mar 23, 2020

Major Issues Report

Current report, item 5.02
Mar 06, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 27, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 20, 2020

Major Issues Report

Current report, item 5.02
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 27, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 29, 2019

Major Issues Report

Current report, item 5.02